Apimeds Pharmaceuticals US, Inc.
APUS· NYSE
Apimeds Pharmaceuticals US, Inc.
- Last sale
- Oct 2, 2026 · -24.63%
- Market cap
- $5.01M
- 1.51M shares
- Filings
- 126
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,632,581 | reported | |
| FY 2023 | 2023-12-31 | $98,544 | reported |
Apimeds Pharmaceuticals US, Inc. · CIK 1894525 · Engraved from SEC EDGAR
